Literature DB >> 5323969

Resistance to purine antagonists in experimental leukemia systems.

R W Brockman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5323969

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

Review 1.  Molecular pharmacodynamics in childhood leukemia.

Authors:  R Pieters; M L den Boer
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

Review 2.  Somatic cell genetics.

Authors:  S Goldstein
Journal:  Can Med Assoc J       Date:  1971-10-09       Impact factor: 8.262

3.  Comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.

Authors:  T Higuchi; T Nakamura; H Uchino; G Wakisaka
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

4.  Studies on the nature of the regulation by purine nucleotides of adenine phosphoribosyltransferase and of hypoxanthine phosphoribosyltransferase from Ehrlich ascites-tumour cells.

Authors:  A W Murray
Journal:  Biochem J       Date:  1967-04       Impact factor: 3.857

5.  The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism.

Authors:  W N Kelley; F M Rosenbloom; J E Seegmiller
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

6.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03

7.  Genetic separation of hypoxanthine and guanine-xanthine phosphoribosyltransferase activities by deletion mutations in Salmonella typhimurium.

Authors:  J S Gots; C E Benson; S R Shumas
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

8.  Mutant of yeast sensitive to 2,6-diaminopurine.

Authors:  C A Lomax; R A Woods
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.